Latest News

Seven Years on the Frontline of Harm Reduction!

2020 marks the 7th year that TB HIV Care has been working at the frontlines of harm reduction in South Africa. TB HIV Care accompanied on this journey by Mainline, have provided financial, technical and emotional support to move forward policy and programmes for people who use drugs (PWUD) in South Africa and most importantly work with the community of PWUD to regain dignity and work towards self-empowerment. TB HIV Care has developed a Harm Reduction track record, which highlights the major events and turning points in this journey, as well as some of the impacts of this work, and includes recommendations for the future.

The Step Up Project has reached over 5 000 people who inject drugs in four South African cities, distributed over 1.7 million needles and syringes. It has provided opportunities for the voices of PWUD to inform the National Drug Master Plan. The project continues to advocate for the rights of PWUD and is also supported by the Global Fund, Open Society Foundations and the Cape Town Central Improvement District. The track record does not name all the people involved. Still, it remains a group effort, and this work would not have been possible without the passion and commitment of the teams who work in the field, the support staff, and most importantly the community of people who use drugs.

Read more about our harm reduction track record here:
THC Harm Reduction Track Record

Educational information on COVID-19

The global pandemic of coronavirus disease 2019 (COVID-19) was first reported on 31 December 2019 by the World Health Organization following a cluster of pneumonia cases in Wuhan City, Hubei Province of China. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been confirmed as the causative virus of COVID-19. COVID-19 has become a global pandemic, and it is continuing to spread across the globe.

TB HIV Care aims to keep you updated with current information concerning COVID-19, ranging from frequently asked questions, information on prevention, screening, and testing.

Below is some important information on knowing the importance of why you should get tested for HIV during the time of COVID-19, and what is the link between TB and COVID-19 in South Africa’s indigenous languages.

Take care of yourself and take care of others.  Stay safe!

Printable flyers on COVID-19


Afrikaans – COVID19 KNOWLEDGE IS POWER_JH5 Print Ready

Ndebele – COVID19 KNOWLEDGE IS POWER_JH2 Print Ready


Tswana – COVID19 KNOWLEDGE IS POWER_JH12 Print Ready



Information from the World Health Organization:

The official South African coronavirus page:

South African statistics on coronavirus:

THC: Request for Proposals

Tuberculosis (TB) is one of the leading causes of mortality in South Africa particularly amongst people
living with HIV. One of the risk factors that contribute to mortality among people with TB disease is poor
adherence to treatment. Household food insecurity is highlighted as being one of the underlying causes of
poor adherence to treatment. This is often driven by lack of economic power to purchase food and
inequitable intra-household access to food, among others (Abdu-RaheemI & Worth, 2011).
Household food insecurity often results in undernutrition, a risk factor for TB disease (WHO, 2019).

The National Department of Health (NDoH) is one of the four Principal Recipients (PRs) appointed to
implement Global Fund TB/HIV programmes from the 1st April 2019 to 31st March 2022. TB HIV Care, a
sub-recipient, is mandated to implement a TB programme with an additional nutrition programme as a
support strategy. The aim of the nutrition programmme is to ensure that TB patients with either drug
sensitive TB or drug resistant TB are provided with a food parcel during the treatment period or up to a
determined period.

TB HIV Care requires the services of a service provider for the provision of pre-packaged food parcels and their distribution.

More details are outlined in the provided documents:

FB_V2_TB Programme_Call for bid proposals

FB_VO2 CBO 2020_04_Terms of Reference